Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
Innoscripta after searches over suspected tax offenses: stock plunges 57%
Innoscripta reported searches in connection with a criminal tax investigation into suspected assistance in obtaining unjustified tax advantages for research allowances by customers. The share then fell by 57% and continued to lose value, while the company says it is examining possible misconduct by individual employees. Analysts such as Warburg Research suspended ratings and price targets and warn of risks including refunds, customer losses, liability claims or fines; the financial consequences remain unclear. » More on deraktionaer.de
Searches at innoscripta over investigations into research allowances
Business premises of innoscripta were searched following two orders from the Amtsgericht Schwäbisch Gmünd in a tax-criminal proceeding on suspicion of aiding the procurement of unauthorized research allowances. According to the search warrants, the investigations concern possible misconduct by individual employees in handling certain client mandates. The company is conducting a thorough review of the matters, is cooperating with the authorities and emphasizes that decisions on applications and responsibility for information lie with the clients. Any effects on the innoscripta group cannot yet be conclusively assessed. » More on finanzen.net
Innoscripta reports strong growth, international expansion and higher earnings
Innoscripta reports a 43% revenue increase and a 49% rise in EBIT in the first half, driven by strong new customer acquisition; the customer base grew to over 2,900. The company is expanding with new offices in the UK, France and the US and expects significant foreign revenues from 2027. Management emphasizes the use of AI to boost efficiency, employee share participation as a retention tool, and aims to develop a global R&D software platform over the long term, while the share price lags behind operational progress. » More on deraktionaer.de